[1]
Martin Czejka, Andreas Kiss, Eva Ostermann, Johannes Schueller, Mansoor Ahmed, Najia Mansoor and Tasneem Ahmad 2013. Metabolic Activation and Inactivation of Irinotecan when Combined with the Human Monoclonal Antibody Bevacizumab. Journal of Analytical Oncology. 2, 4 (Dec. 2013),  218–225. DOI:https://doi.org/10.6000/1927-7229.2013.02.04.4.